IL-6 expressed by tumor cells, both in mouse models and in CRC patients, is critical in modeling immune responses in cancer, as well as inducing strong immunosuppression in the CRC microenvironment [97,144]. The gene discussed is IL6; the disease is colorectal carcinoma.